Verrier QY, Serrano VNL, Campos HM

Language: Spanish
References: 22
Page:
PDF size: 245.87 Kb.

ABSTRACT

Introduction: The incidence of endometrial cancer has increased and it is associated with risk factors present in many perimenopausewomen. The most common symptom is bleeding and the most widely used treatment modality is surgery.
Objective: Characterize endometrial cancer at "America Arias" Hospital from January 2010 to June 2013.
Methods: A descriptive study was conductedat "America Arias" Hospital, from 1 January 2010 to 30 June 2013. The total included over 40 year patients with abnormal uterine bleeding in perimenopausal and postmenopausal. Patients with histopathologic diagnosis of endometrial cancer constituted the sample (n= 49).
Results: The mean age of patients was 60.8 ± 9.9 years. 30.6 % were overweight and 44.9 % were obese. Postoperative histopathologic examination shows that the lesion was limited to the endometrium in 14.3 % of patients, but there was invasion of the two outer thirds of the myometrium in 61.2 %. The extension cervix and adnexa was 38.8 % and 22.4 %, respectively.
Conclusions: There is a tendency to the appearance of endometrial adenocarcinoma at increasingly advanced ages. It is associated with risk factors such as obesity, infertility, and the use of hormone replacement therapy. In addition to surgery, some patients required specific cancer treatment.

REFERENCES

1. American Cancer Society. Cancer Facts and Figures 2009. Atlanta. Ga: American Cancer Society; 2009. [citado 6 de junio de 2015]. Disponible en: http://www.cancer.org/acs/groups/content/@nho/documents/document/500809we bpdf.pdf

2. Domínguez Alonso E, Seuc Jo AH, Galán Y. La carga de enfermedad por cáncer en Cuba en el período 1990-2002. Rev Panam Salud Publica [online]. 2009 [citado 30 de noviembre de 2015];26(5):412-8. Disponible en: http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020- 49892009001100005&lng=en&nrm=iso ISSN 1020- 4989. http://dx.doi.org/10.1590/S1020-49892009001100005

3. Scucces M. Epidemiología del carcinoma de endometrio. Rev Obstet Ginecol Venez [revista en internet]. 2001 Mar [citado 17 de diciembre de 2013];70(1):37-41. Disponible en: http://www.scielo.php?script=sci arttext&pid=S0048- 77322010000100007&Ing=es

4. Kurman RJ, Ellenson LH, Ronnett BM. (Eds.). Blaustein’s Pathology of the Female Genital Tract. 6th Edition.

5. Pérez M. Ginecología Oncológica Pelviana. La Habana: Editorial Ciencias Médicas; 2006. p. 217-41.

6. Cabezas Cruz E, Cutié León E, Santisteban Alba S, Castell Moreno J, Díaz Mitjans O, Herrera Alcázar V, et al. Manual de Procedimientos en Ginecología. La Habana: Editorial Ciencias Médicas; 2006. p. 79-87.

7. Yang TYO, Cairos BJ, Allen N, Sweetland S, Reeves GK, Beral V. Postmenopausal endometrial cancer risk and body size in early life and middle age: prospective cohort study. British Journal of Cancer. 2012;107:169-75.

8. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide. Lyon, France: International Agency for Research on Cancer: IARC Cancer Base No. 10, 2010.

9. Salgueiro VE, Sanabria JG, Abreu MC. Cáncer cérvico-uterino en la tercera edad 2005-2008. Rev Ciencias Méd. 2009;13(4). ISSN 1561-3194.

10. Lantyer N, Abensur D. Terapia de reposição hormonal e o câncer do endométrio. Cad. Saúde Pública. 2007[citado 30 de noviembre de 2015];23(11). Disponible en: http://dx.doi.org/10.1590/S0102-311X2007001100009

11. Phipps AI, Doherty JA, Voigt LF, Hill DA, Beresford SAA, Rossing MA, Chen C, Weiss NS. Long-term Use of Continuous-Combined Estrogen-Progestin Hormone Therapy and Risk of Endometrial Cancer. Cancer Causes Control. 2011;22(12):1639-46. doi: 10.1007/s10552-011-9840-6.

12. Bereck JS, Hillard PA, Adashi EY. Ginecología de Novak. 14ª edición. Mac Graw-Hill interamericana Editores S.A., de CV. 2007. p. 1343-82.

13. Tratado de Ginecología de J Botella Llusiá y J A Clavero Núñez Tomo III. 14ª edición. p. 899-902.

14. Cabezas Cruz E, Cutié León E, Santisteban Alba S, Castell Moreno J, Díaz Mitjans O, Herrera Alcázar V, et al. Manual de Procedimientos en Ginecología. La Habana: Editorial Ciencias Médicas; 2006. p. 138-43.

15. Salamanca Gómez F. Tamoxifén y carcinogénesis en el endometrio. Gac. Méd. Méx. 2006;142(2).

16. Sanhueza P, Oliva L. Eficiencia de los métodos diagnósticos en el estudio del sangrado uterino anormal en la peri y postmenopausia. Rev Chil Obstet Ginecol. 2008[citado 30 de noviembre de 2015];73(1):58-62. Disponible en: http://dx.doi.org/10.4067/S0717-75262008000100010

17. Viscomi FA, Rolim SM, Lima R, Mendes J, Kürten MF. Freqüência de Adenocarcinoma de Endométrio em Ambulatório de Histeroscopia: Um Estudo Multicêntrico. Rev. Bras. Ginecol. Obstet. 2002;24(1). Disponible en: http://dx.doi.org/10.1590/S0100-72032002000100007

18. Ferreira HL, Bregieiro LO. Histeroscopia na menopausa: análise das técnicas e acurácia do método. Rev. Bras. Ginecol. Obstet. 2008[citado 30 de noviembre de 2015];30(10). Disponible en: http://dx.doi.org/10.1590/S0100-72032008001000008

19. Barrero R, Barrero D, Alonso C, García G, Vargas V, Rivera R, Larraín A. Correlación anatomopatológica de las hiperplasias endometriales antes y después de la histerectomía. Rev Chil Obstet Ginecol. 2008[citado 30 de noviembre de 2015];73(2):91-7. Disponible en: http://dx.doi.org/10.4067/S0717- 75262008000200004

20. Salud/Sedena/Semar. Diagnóstico y Tratamiento del Cáncer de Endometrio. México: Secretaría de Salud, 2010. ISBN: 978-607-7790-70-9 [on line] [citado 30 de noviembre de 2015] Disponible en: www.cenetec.salud.gob.mx/interior/gpc.html

21. Creasman WT. Endometrial cancer: incidence, prognostic factors, diagnosis and treatment. Semin Oncol. 1997;24:140-50.

22. Morrow CP, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991;40:55-65.